Vivo Capital, LLC Delcath Systems, Inc. Transaction History
Vivo Capital, LLC
- $748 Million
- Q1 2024
A detailed history of Vivo Capital, LLC transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Vivo Capital, LLC holds 1,666,746 shares of DCTH stock, worth $14 Million. This represents 1.06% of its overall portfolio holdings.
Number of Shares
1,666,746
Previous 855,191
94.9%
Holding current value
$14 Million
Previous $3.56 Million
123.5%
% of portfolio
1.06%
Previous 0.44%
Shares
4 transactions
Others Institutions Holding DCTH
# of Institutions
40Shares Held
7.37MCall Options Held
143KPut Options Held
60.8K-
Aigh Capital Management LLC Baltimore, MD2.36MShares$19.8 Million4.54% of portfolio
-
Bvf Inc San Francisco, CA1.2MShares$10.1 Million0.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA684KShares$5.72 Million0.0% of portfolio
-
Cibc World Market Inc. Toronto, A6260KShares$2.18 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA223KShares$1.87 Million0.0% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $72M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...